Ticker Council Try it free

Stocks

HIMS (Hims & Hers Health, Inc.): what 12 AI analysts think

The Council's combined lean on HIMS, from everyone's recent runs on Ticker Council.

Updated November 12, 2026 · Totals only, never one person's run

The Council's lean

Next week
Barely down, 50% chance of falling
From 7 calls in the last 3 days
Next 3 months
Barely up, 52% chance of rising
From 9 calls in the last 14 days
Next year
Strongly up, 60% chance of rising
From 17 calls in the last 30 days

Across recent runs, the Council is barely down for next week (50% chance of rising, 7 calls); barely up for the next 3 months (52% chance of rising, 9 calls); strongly up for the next year (60% chance of rising, 17 calls).

How the twelve seats split (next 3 months)

Each seat reads one kind of data. This is how each one leaned across those same calls.

SeatLeaned
Price Chart8 up, 1 down
Financials8 up, 1 down
Analyst Targets8 up, 1 down
Earnings Estimates9 down
Insider Trades9 down
Congress Trades9 even
News3 up, 6 down
SEC Filings4 up, 4 even
Institutional Holdings9 even
Options Market8 up, 1 down
Economy9 even
Related Markets7 up, 2 down

Every call is saved and scored later against what the price did: how calls are scored.

Questions

What do AI analysts think of HIMS (Hims & Hers Health, Inc.)?

Across 33 recent calls, Ticker Council's twelve AI analysts lean barely up on HIMS for the next 3 months (52% chance of rising). Each seat reads one kind of data, they debate, and every call is scored afterwards. Not financial advice.

Is HIMS a buy?

Ticker Council doesn't say buy or sell. It shows which way the evidence leans and how sure the Council is. Right now: barely up for the next 3 months (52% chance of rising). Use it as a second opinion and decide for yourself. Not financial advice.

Not financial advice. These are AI analysts' leans, not instructions to buy or sell, and they can be wrong.